Treatment Pattern and Outcomes with Systemic Therapy in Men with Metastatic Prostate Cancer in the Real-World Patients in the United States

SIMPLE SUMMARY: Novel hormonal therapies (such as abiraterone and enzalutamide) and docetaxel are approved treatments for metastatic prostate cancer. Upfront use of these agents has been shown to improve overall survival. However, we do not know the real-world treatment patterns of these agents or t...

Descripción completa

Detalles Bibliográficos
Autores principales: Swami, Umang, Sinnott, Jennifer Anne, Haaland, Benjamin, Sayegh, Nicolas, McFarland, Taylor Ryan, Tripathi, Nishita, Maughan, Benjamin L., Rathi, Nityam, Sirohi, Deepika, Nussenzveig, Roberto, Kohli, Manish, Pal, Sumanta K., Agarwal, Neeraj
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8508241/
https://www.ncbi.nlm.nih.gov/pubmed/34638435
http://dx.doi.org/10.3390/cancers13194951

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8508241/
https://www.ncbi.nlm.nih.gov/pubmed/34638435
http://dx.doi.org/10.3390/cancers13194951

Ejemplares similares